Neuroblastoma is one of the most common solid tumors in children, and approximately 700 patients are diagnosed each year in the United States. We care for patients of all ages diagnosed with neuroblastic lesions, from benign masses to highly aggressive, malignant tumors. Our program is focused not only on methods to improve our current care platform, but also to incorporate additional non-toxic treatment options to improve cure rates. Our comprehensive treatment options include surgery, radiation therapy, high-dose chemotherapy with stem cell rescue, and immunotherapy with antibody, T cells and/or vaccines.
Texas Children’s Cancer Center offers MIBG therapy for patients with high-risk relapsed or refractory neuroblastoma. In keeping with our mission to provide personalized, comprehensive services as well as family-centered care for every patient, I-131MIBG treatment is offered to patients in a two-room suite that allows a parent to stay close to their child throughout the length of treatment. A viewing window separates the two rooms. In addition to an intercom system between the rooms, both patient and parent will be provided with iPads for communication. The patient room is equipped to manage safe delivery of therapy to the patient as well as protect staff and parents from unwanted radiation when entering the room for short periods of time. The parent room is fully equipped with a bed, couch, and full private bathroom.